» Articles » PMID: 20737047

Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation

Overview
Specialty Hematology
Date 2010 Aug 26
PMID 20737047
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular therapies that either use modifications of a patient's own cells or allogeneic cell lines are becoming in vogue. Besides the technical issues of optimal isolation, cultivation and modification, quality control of the generated cellular products are increasingly being considered to be more important. This is not only relevant for the cell's therapeutic application but also for cell science in general. Recent changes in editorial policies of respected journals, which now require proof of authenticity when cell lines are used, demonstrate that the subject of the present paper is not a virtual problem at all. In this article we provide 2 examples of contaminated cell lines followed by a review of the recent developments used to verify cell lines, stem cells and modifications of autologous cells. With relative simple techniques one can now prove the authenticity and the quality of the cellular material of interest and therefore improve the scientific basis for the development of cells for therapeutic applications. The future of advanced cellular therapies will require production and characterization of cells under GMP and GLP conditions, which include proof of identity, safety and functionality and absence of contamination.

Citing Articles

Cultured Meat Safety Research Priorities: Regulatory and Governmental Perspectives.

Ong K, Tejeda-Saldana Y, Duffy B, Holmes D, Kukk K, Shatkin J Foods. 2023; 12(14).

PMID: 37509737 PMC: 10379195. DOI: 10.3390/foods12142645.


Advanced technologies for the preservation of mammalian biospecimens.

Huang H, He X, Yarmush M Nat Biomed Eng. 2021; 5(8):793-804.

PMID: 34426675 PMC: 8765766. DOI: 10.1038/s41551-021-00784-z.


Are your results valid? Cellular authentication a need from the past, an emergency on the present.

Cosme B, Falagan-Lotsch P, Ribeiro M, Napoleao K, Granjeiro J, Moura-Neto R In Vitro Cell Dev Biol Anim. 2017; 53(5):430-434.

PMID: 28127703 DOI: 10.1007/s11626-016-0124-z.


What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?.

Barcia R, Santos J, Filipe M, Teixeira M, Martins J, Almeida J Stem Cells Int. 2015; 2015:583984.

PMID: 26064137 PMC: 4443932. DOI: 10.1155/2015/583984.


Cell therapy of periodontium: from animal to human?.

Trofin E, Monsarrat P, Kemoun P Front Physiol. 2013; 4:325.

PMID: 24298258 PMC: 3828527. DOI: 10.3389/fphys.2013.00325.


References
1.
Markovic O, Markovic N . Cell cross-contamination in cell cultures: the silent and neglected danger. In Vitro Cell Dev Biol Anim. 1998; 34(1):1-8. DOI: 10.1007/s11626-998-0040-y. View

2.
Draper J, Smith K, Gokhale P, Moore H, Maltby E, Johnson J . Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2003; 22(1):53-4. DOI: 10.1038/nbt922. View

3.
Lange C, Cakiroglu F, Spiess A, Cappallo-Obermann H, Dierlamm J, Zander A . Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol. 2007; 213(1):18-26. DOI: 10.1002/jcp.21081. View

4.
Torroni A, Brown M, Lott M, Newman N, Wallace D . African, Native American, and European mitochondrial DNAs in Cubans from Pinar del Rio Province and implications for the recent epidemic neuropathy in Cuba. Cuba Neuropathy Field Investigation Team. Hum Mutat. 1995; 5(4):310-7. DOI: 10.1002/humu.1380050407. View

5.
Bartlett S, Davidson W . FINS (forensically informative nucleotide sequencing): a procedure for identifying the animal origin of biological specimens. Biotechniques. 1992; 12(3):408-11. View